VICARIOUS SURGICAL INC. Research and Development Expense
VICARIOUS SURGICAL INC. (RBOT) reported Research and Development Expense of $33.60 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-03-09
- VICARIOUS SURGICAL INC. research and development expense for the quarter ending 2025-12-31 was $7.14M, a 15.60% decline year-over-year.
- VICARIOUS SURGICAL INC. research and development expense for the quarter ending 2025-09-30 was $7.99M, a 25.99% decline year-over-year.
- VICARIOUS SURGICAL INC. research and development expense for the quarter ending 2025-06-30 was $9.05M, a 17.15% decline year-over-year.
- VICARIOUS SURGICAL INC. research and development expense for the quarter ending 2025-03-31 was $9.41M, a 5.55% decline year-over-year.
- VICARIOUS SURGICAL INC. research and development expense for fiscal 2025 was $33.60M, a 16.32% decline from fiscal 2024.
- VICARIOUS SURGICAL INC. research and development expense for fiscal 2024 was $40.16M, a 15.60% decline from fiscal 2023.
- VICARIOUS SURGICAL INC. research and development expense for fiscal 2023 was $47.58M, a 8.38% increase from fiscal 2022.
- VICARIOUS SURGICAL INC. research and development expense for fiscal 2022 was $43.90M, a 99.01% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2025-12-31 | $7.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $15.14M derived: sum of 2 quarters · filed 2026-03-09 | $24.19M derived: sum of 3 quarters · filed 2026-03-09 | $33.60M 10-K · filed 2026-03-09 |
| 2025-09-30 | $7.99M 10-Q · filed 2025-11-12 | $17.04M derived: sum of 2 quarters · filed 2025-11-12 | $26.46M 10-Q · filed 2025-11-12 | $34.92M derived: sum of 4 quarters · filed 2026-03-09 |
| 2025-06-30 | $9.05M 10-Q · filed 2025-08-12 | $18.46M 10-Q · filed 2025-08-12 | $26.93M derived: sum of 3 quarters · filed 2026-03-09 | $37.73M derived: sum of 4 quarters · filed 2026-03-09 |
| 2025-03-31 | $9.41M 10-Q · filed 2025-05-12 | $17.88M derived: sum of 2 quarters · filed 2026-03-09 | $28.68M derived: sum of 3 quarters · filed 2026-03-09 | $39.60M derived: sum of 4 quarters · filed 2026-03-09 |
| 2024-12-31 | $8.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $19.26M derived: sum of 2 quarters · filed 2026-03-09 | $30.19M derived: sum of 3 quarters · filed 2026-03-09 | $40.16M 10-K · filed 2026-03-09 |
| 2024-09-30 | $10.80M 10-Q · filed 2025-11-12 | $21.72M derived: sum of 2 quarters · filed 2025-11-12 | $31.69M 10-Q · filed 2025-11-12 | $40.16M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $10.92M 10-Q · filed 2025-08-12 | $20.89M 10-Q · filed 2025-08-12 | $29.36M derived: sum of 3 quarters · filed 2025-08-12 | $42.40M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $9.97M 10-Q · filed 2025-05-12 | $18.44M derived: sum of 2 quarters · filed 2025-05-12 | $31.48M derived: sum of 3 quarters · filed 2025-05-12 | $44.19M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $8.47M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $21.51M derived: sum of 2 quarters · filed 2025-03-17 | $34.22M derived: sum of 3 quarters · filed 2025-03-17 | $47.58M 10-K · filed 2025-03-17 |
| 2023-09-30 | $13.04M 10-Q · filed 2024-11-12 | $25.75M derived: sum of 2 quarters · filed 2024-11-12 | $39.11M 10-Q · filed 2024-11-12 | $50.99M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $12.71M 10-Q · filed 2024-08-13 | $26.07M 10-Q · filed 2024-08-13 | $37.95M derived: sum of 3 quarters · filed 2024-08-13 | $50.07M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $13.36M 10-Q · filed 2024-04-29 | $25.23M derived: sum of 2 quarters · filed 2024-04-29 | $37.35M derived: sum of 3 quarters · filed 2024-04-29 | $47.41M derived: sum of 4 quarters · filed 2024-04-29 |
| 2022-12-31 | $11.88M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-04 | $24.00M derived: sum of 2 quarters · filed 2024-03-04 | $34.05M derived: sum of 3 quarters · filed 2024-03-04 | $43.90M 10-K · filed 2024-03-04 |
| 2022-09-30 | $12.12M 10-Q · filed 2023-11-13 | $22.18M derived: sum of 2 quarters · filed 2023-11-13 | $32.02M 10-Q · filed 2023-11-13 | $41.28M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $10.05M 10-Q · filed 2023-07-28 | $19.90M 10-Q · filed 2023-07-28 | $29.16M derived: sum of 3 quarters · filed 2023-07-28 | $34.35M derived: sum of 4 quarters · filed 2023-07-28 |
| 2022-03-31 | $9.85M 10-Q · filed 2023-05-08 | $19.10M derived: sum of 2 quarters · filed 2023-05-08 | $24.29M derived: sum of 3 quarters · filed 2023-05-08 | $28.30M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $9.26M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | $14.44M derived: sum of 2 quarters · filed 2023-02-15 | $18.45M derived: sum of 3 quarters · filed 2023-02-15 | $22.06M 10-K · filed 2023-02-15 |
| 2021-09-30 | $5.19M 10-Q · filed 2022-11-07 | $9.20M derived: sum of 2 quarters · filed 2022-11-07 | $12.80M 10-Q · filed 2022-11-07 | $15.77M derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | $4.01M 10-Q · filed 2022-08-08 | $7.62M 10-Q · filed 2022-08-08 | $10.58M derived: sum of 3 quarters · filed 2022-08-08 | $13.08M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $3.61M 10-Q · filed 2022-05-09 | $6.57M derived: sum of 2 quarters · filed 2022-05-09 | $9.08M derived: sum of 3 quarters · filed 2022-05-09 | |
| 2020-12-31 | $2.96M derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-03-31 | $5.47M derived: sum of 2 quarters · filed 2022-03-31 | $9.80M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $2.50M 10-Q/A · filed 2022-03-31 | $6.83M 10-Q/A · filed 2022-03-31 |